The agency's approval of the Pfizer-BioNTech vaccine — shown to be 95% effective — would go beyond the speedier and less rigorous emergency use authorization currently granted to the vaccine.
Copyright 2021 NPR
© 2024
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations